Dr. John H. Powers III will lead the National Institute of Allergy and Infectious Diseases. The appointment places him in a role held for decades by Dr. Anthony Fauci.
The position carries major influence over U.S. infectious disease research and public health policy. NIAID funds and directs work on allergies, immunology, and emerging infections.
Powers takes over at a turbulent time for the agency. Leadership changes and political pressure have unsettled staff and outside researchers.
He is a physician and researcher known for his work on clinical trial design and drug development. His background spans academic medicine and federal advisory roles.
The appointment signals a shift in NIAID’s direction after Fauci’s long tenure. Observers will watch how Powers handles pandemic preparedness and vaccine research.
The agency faces scrutiny over funding priorities and public trust. Powers will need to steady operations while addressing calls for reform.
His leadership style and early decisions will shape NIAID’s research agenda. The role remains central to the nation’s response to infectious disease threats.





